PND122 COMPARING WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT OUTCOMES AMONG PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH OCRELIZUMAB VS OTHER DISEASE-MODIFYING THERAPIES

Authors
Category Primary study
JournalValue Health
Year 2020
This article has no abstract
Epistemonikos ID: b968c218c1f1eeebe9b47b794fd2f24a0d2e471a
First added on: May 20, 2020